{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:32:12Z","timestamp":1790929932676,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/bf02686079","type":"journal-article","created":{"date-parts":[[2007,8,16]],"date-time":"2007-08-16T14:17:41Z","timestamp":1187273861000},"source":"Crossref","is-referenced-by-count":56,"title":["Auto-antibodies and autoreactive T-cells in rheumatoid arthritis"],"prefix":"10.1007","volume":"32","author":[{"given":"G\u00fcnter","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"3","key":"BF02686079_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00002281-200405000-00013","volume":"16","author":"T. Dorner","year":"2004","unstructured":"Dorner, T., Egerer, K., Feist, E., and Burmester, G. R. (2004), Rheumatoid factor revisited. Curr Op Rheum 16(3), 246\u2013253.","journal-title":"Curr Op Rheum"},{"issue":"Suppl 2","key":"BF02686079_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar551","volume":"4","author":"G. Steiner","year":"2002","unstructured":"Steiner, G. and Smolen, J. (2002), Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4(Suppl 2), S1-S5.","journal-title":"Arthritis Res"},{"issue":"3","key":"BF02686079_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/ar1184","volume":"6","author":"E. R. Vossenaar","year":"2004","unstructured":"Vossenaar, E. R. and van Venrooij, W. J. (2004), Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 6(3), 107\u2013111.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"BF02686079_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0009-9120(93)90032-2","volume":"26","author":"T. L. Moore","year":"1993","unstructured":"Moore, T. L. and Dorner, R. W. (1993), Rheumatoid factors. Clin Biochem 26(2), 75\u201384.","journal-title":"Clin Biochem"},{"issue":"4","key":"BF02686079_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0167-5699(00)01589-9","volume":"21","author":"B. Sutton","year":"2000","unstructured":"Sutton, B., Corper, A., Bonagura, V., and Taussig, M. (2000), The structure and origin of rheumatoid factors. Immunol Today 21(4), 177\u2013183.","journal-title":"Immunol Today"},{"issue":"10","key":"BF02686079_CR6","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/eji.1830261031","volume":"26","author":"N. Djavad","year":"1996","unstructured":"Djavad, N., Bas, S., Shi, X., et al. (1996), Comparison of rheumatoid factors of rheumatoid arthritis patients, of individuals with myocobacterial infections and of normal controls: evidence for maturation in the absence of an autoimmune response. Eur J Immunol 26(10), 2480\u20132486.","journal-title":"Eur J Immunol"},{"issue":"2","key":"BF02686079_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1365-2249.1999.00963.x","volume":"117","author":"K. E. Elagib","year":"1999","unstructured":"Elagib, K. E., Borretzen, M., Jonsson R., et al. (1999), Kheumatoid factors in primary Sjogren\u2019s syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation. Clin Exp Immunol 117(2), 388\u2013394.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"BF02686079_CR8","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.163.6.3116","volume":"163","author":"D. Kyburz","year":"1999","unstructured":"Kyburz, D., Corr, M., Brinson, D. C., Von Damm, A., Tighe, H., and Carson, D. A. (1999), Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 163(6), 3116\u20133122.","journal-title":"J Immunol"},{"issue":"4","key":"BF02686079_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/art.1780380406","volume":"38","author":"S. Breitner","year":"1995","unstructured":"Breitner, S., Storkel, S., Reichel, W., and Loos, M. (1995), Complement components C1q, C1r\/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures. Arthritis Rheum 38(4), 492\u2013498.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"BF02686079_CR10","first-page":"2074","volume":"29","author":"A. L. Jansen","year":"2002","unstructured":"Jansen, A. L., van der Horst-Bruinsma, I., van Schaardenburg, D., van de Stadt, R. J., de Koning, M. H., and Dijkmans, B. A. (2002), Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29(10), 2074\u20132076.","journal-title":"J Rheumatol"},{"issue":"12","key":"BF02686079_CR11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"V. Nell","year":"2005","unstructured":"Nell, V., Machold, K. P., Stamm, T. A. et al. (2005), Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64(12), 1731\u20131736.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"BF02686079_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"M. M. J. Nielen","year":"2004","unstructured":"Nielen, M. M. J., van Schaardenburg, D., Reesink, H. W. R., et al. (2004), Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurments in blood donors. Arthritis Rheum 50(2), 380\u2013386.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"BF02686079_CR13","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S. Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist, S., de Jong, B. A., Berglin, E. et al. (2003), Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. [see comment], Arthritis Rheum 48(10), 2741\u20132149.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"BF02686079_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","volume":"42","author":"S. Bas","year":"2003","unstructured":"Bas, S., Genevay, S., Meyer, O., and Gabay, C. (2003), Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42(5), 677\u2013680.","journal-title":"Rheumatology"},{"key":"BF02686079_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1196\/annals.1313.031","volume":"1050","author":"A. Greiner","year":"2005","unstructured":"Greiner, A., Plischke, H., Kellner, H., and Gruber, R. (2005), Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann NY Acad Sci, 1050, 295\u2013303.","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"BF02686079_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s002960050069","volume":"18","author":"T. Jonsson","year":"1998","unstructured":"Jonsson, T., Steinsson, K., Jonsson, H., Geirsson, AJ., Thorsteinsson, J., and Valdimarsson, H. (1998), Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis. Rheumatol Int, 18(3), 119\u2013122.","journal-title":"Rheumatol Int"},{"issue":"2","key":"BF02686079_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E. Lindqvist","year":"2005","unstructured":"Lindqvist, E., Eberhardt, K., Bendtzen, K., Heinegard, D., and Saxne, T. (2005), Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64(2), 196\u2013201.","journal-title":"Ann Rheum Dis"},{"key":"BF02686079_CR18","first-page":"124","volume":"39","author":"D. L. Scott","year":"2000","unstructured":"Scott, D. L. (2000), Prognostic factors in early rheumatoid arthritis. Rheumatology (39), 124\u2013129.","journal-title":"Rheumatology"},{"issue":"3","key":"BF02686079_CR19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI116713","volume":"92","author":"M. Simon","year":"1993","unstructured":"Simon, M., Girbal, E., Sebbag, M., et al. (1993). The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \u201cantikeratin antibodies,\u201d autoantibodies specific for rheumatoid arthritis. J Clin Invest 92(3), 1387\u20131393.","journal-title":"J Clin Invest"},{"issue":"4","key":"BF02686079_CR20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000237093","volume":"107","author":"P. Youinou","year":"1995","unstructured":"Youinou, P. and Serre, G. (1995), The antiperinuclear factor and antikeratin antibody systems. Int Arch Allergy Immunol 107(4), 508\u2013518.","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"BF02686079_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/sj.jidsp.5640198","volume":"4","author":"A. Ishida Yamamoto","year":"1999","unstructured":"Ishida Yamamoto, A., Tanaka, H., Nakane, H., Takahashi, H., Hashimoto, Y., and Iizuka, H. (1999), Programmed cell death in normal epidermis and loricrin keratoderma. Multiple functions of profilaggrin in keratinization. J Investig Dermatol Symp Proc 4 (2), 145\u2013149.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"BF02686079_CR22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E. Girbal Neuhauser","year":"1999","unstructured":"Girbal Neuhauser, E., Durieux, J. J., Arnaud, M., et al. (1999), The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162(1), 585\u2013594.","journal-title":"J Immunol"},{"issue":"1","key":"BF02686079_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"G. A. Schellekens","year":"1998","unstructured":"Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., and van Venrooij, W. J. (1998), Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101(1), 273\u2013281.","journal-title":"J Clin Invest"},{"issue":"5","key":"BF02686079_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/art.10229","volume":"46","author":"A. Union","year":"2002","unstructured":"Union, A., Meheus, L., Humbel, R. L., et al. (2002), Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by LINE immunoassay. Arthritis Rheum 46(5), 1185\u20131193.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"BF02686079_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"G. A. Schellekens","year":"2000","unstructured":"Schellekens, G. A., Visser, H., de Jong, B. A., et al. (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43(1), 155\u2013163.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"BF02686079_CR26","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C. Masson-Bessiere","year":"2001","unstructured":"Masson-Bessiere, C., Sebbag, M., Girbal-Neuhauser, E., et al. (2001), The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 166(6) 4177\u20134184.","journal-title":"J Immunol"},{"issue":"8","key":"BF02686079_CR27","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.174.8.5057","volume":"174","author":"S. Chapuy-Regaud","year":"2005","unstructured":"Chapuy-Regaud, S., Sebbag, M., Baeten, D., et al. (2005), Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J Immunol 174(8), 5057\u20135064.","journal-title":"J Immunol"},{"issue":"11","key":"BF02686079_CR28","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/art.20584","volume":"50","author":"E. R. Vossenaar","year":"2004","unstructured":"Vossenaar, E. R., Smeets, T. J., Kraan, M. C., Raats, J. M., van Venrooij, W. J. and Tak, P. P. (2004), The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50(11), 3485\u20133494.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"BF02686079_CR29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/ard.2004.029389","volume":"64","author":"M. M. Nielen","year":"2005","unstructured":"Nielen, M. M., van der Horst, A. R., van Schaardenburg, D., et al. (2005), Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 64(8), 1199\u20131204.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"BF02686079_CR30","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/art.21220","volume":"52","author":"L. De Rycke","year":"2005","unstructured":"De Rycke, L., Nicholas, A. P., Cantaert, T., et al. (2005), Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum 52(8), 2323\u20132330.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"BF02686079_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01171.x","volume":"119","author":"C. Masson-Bessiere","year":"2000","unstructured":"Masson-Bessiere, C., Sebbag, M., Durieux, J. J., et al. (2000), In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 119(3), 544\u2013552.","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"BF02686079_CR32","first-page":"1691","volume":"30","author":"L. M. Jansen","year":"2003","unstructured":"Jansen, L. M., van Schaardenburg, D., van der Horst-Bruinsma, I., van der Stadt, R. J., de Koning, M. H., and Dijkmans, B. A. (2003), The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 30(8), 1691\u20131695.","journal-title":"J Rheumatol"},{"issue":"3","key":"BF02686079_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"F. A. van Gaalen","year":"2004","unstructured":"van Gaalen, F. A., Linn-Rasker, S. P., van Venrooij, W. J., et al. (2004a), Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50(3), 709\u2013715.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"BF02686079_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H. Visser","year":"2002","unstructured":"Visser, H., le Cessie, S., Vos, K., Breedveld, F. C., and Hazes, J. M. (2002), How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46(2), 357\u2013365.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"BF02686079_CR35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A. Kastbom","year":"2004","unstructured":"Kastbom, A., Strandberg, G., Lindroos, A., and Skogh, T. (2004), Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63(9), 1085\u20131089.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"BF02686079_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ard.62.2.120","volume":"62","author":"O. Meyer","year":"2003","unstructured":"Meyer, O., Labarre, C., Dougados, M., et al. (2003), Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62(2), 120\u2013126.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"BF02686079_CR37","doi-asserted-by":"publisher","first-page":"R303","DOI":"10.1186\/ar1187","volume":"6","author":"E. Berglin","year":"2004","unstructured":"Berglin, E., Padyukov, L., Sundin, U., et al. (2004) A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 6(4), R303-R308.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"BF02686079_CR38","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/art.20316","volume":"50","author":"F. A. van Gaalen","year":"2004","unstructured":"van Gaalen, F. A., van Aken, J., Huizinga, T. W., et al. (2004c), Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 50(7), 2113\u20132121.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"BF02686079_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000237386","volume":"111","author":"G. Steiner","year":"1996","unstructured":"Steiner, G., Skriner, K., and Smolen, J. S. (1996), Autoantibodies to the A\/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases. Int Arch Allergy Immunol 111(4), 314\u2013319.","journal-title":"Int Arch Allergy Immunol"},{"key":"BF02686079_CR40","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.169.2.1068","volume":"169","author":"R. Fritsch","year":"2002","unstructured":"Fritsch, R., Eselb\u00f6ck, D., Skriner, K., Jahn-Schmid, B., et al. (2002), Characterization of autoreactive T cells to the autoantigens RA33 (hnRNP A2) and filaggrin in patients with rheumatoid arthritis. J Immunol 169, 1068\u20131076.","journal-title":"J Immunol"},{"issue":"12","key":"BF02686079_CR41","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.4049\/jimmunol.175.12.8327","volume":"175","author":"S. Hayer","year":"2005","unstructured":"Hayer, S., Tohidast-Akrad, M., Haralambous, S., et al. (2005), Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice. J Immunol 175(12), 8327\u20138336.","journal-title":"J Immunol"},{"issue":"2","key":"BF02686079_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1006\/excr.1998.4323","volume":"246","author":"H. Kamma","year":"1999","unstructured":"Kamma, H., Horiguchi, H., Wan, L., et al. (1999), Molecular characterization of the hnRNP A2\/B1 proteins: tissue-specific expression and novel isoforms. Exp Cell Res 246(2), 399\u2013411.","journal-title":"Exp Cell Res"},{"issue":"6","key":"BF02686079_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/art.1780380610","volume":"38","author":"W. Hassfeld","year":"1995","unstructured":"Hassfeld, W., Steiner, G., Studnicka Benke, A., et al. (1995), Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 38(6) 777\u2013785.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"BF02686079_CR44","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4049\/jimmunol.162.2.1018","volume":"162","author":"D. Plows","year":"1999","unstructured":"Plows, D., Kontogeorgos, G., and Kollias, G. (1999), Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. J Immunol 162(2), 1018\u20131023.","journal-title":"J Immunol"},{"issue":"5","key":"BF02686079_CR45","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/eji.200526000","volume":"35","author":"H. Burkhardt","year":"2005","unstructured":"Burkhardt, H., Sehnert, B., Bockermann, R., Engstrom, A., Kalden, J. R., and Holmdahl, R. (2005), Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 35(5), 1643\u20131652.","journal-title":"Eur J Immunol"},{"issue":"2","key":"BF02686079_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbrc.2005.05.137","volume":"333","author":"A. Suzuki","year":"2005","unstructured":"Suzuki, A., Yamada, R., Ohtake-Yamanaka, M., Okazaki, Y., Sawada, T., and Yamamoto, K. (2005), Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Comm 333(2), 418\u2013426.","journal-title":"Biochem Biophys Res Comm"},{"issue":"10","key":"BF02686079_CR47","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/art.1780391015","volume":"39","author":"A. D. Cook","year":"1996","unstructured":"Cook, A. D., Rowley, M. J., Mackay, I. R., Gough, A., and Emery, P. (1996), Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum 39(10), 1720\u20131727.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"BF02686079_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CMR.12.1.19","volume":"12","author":"U. Zugel","year":"1999","unstructured":"Zugel, U., and Kaufmann, S. H. (1999), Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 12(1), 19\u201339.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"BF02686079_CR49","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/rheumatology\/keh312","volume":"43","author":"M. D. Bodman-Smith","year":"2004","unstructured":"Bodman-Smith, M. D., Corrigall, V. M., Berglin, E., et al. (2004), Antibody response to the human stress protein BiP in rheumatoid arthritis. Rheumatology 43(10), 1283\u20131287.","journal-title":"Rheumatology"},{"issue":"2","key":"BF02686079_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S0049-0172(96)80043-6","volume":"26","author":"M. Tishler","year":"1996","unstructured":"Tishler, M. and Shoenfeld, Y. (1996), Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. Semin Arthritis Rheum 26(2), 558\u2013563.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"BF02686079_CR51","first-page":"83","volume":"103","author":"R. N. Barker","year":"1996","unstructured":"Barker, R. N., Wells, A. D., Ghoraishian, M., et al. (1996), Expression of mammalian 60-kD heat shock protein in the joints of mice with pristane-induced arthritis. Clin Exp Immunol 103(1), 83\u201388.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"BF02686079_CR52","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI2465","volume":"102","author":"G. Schett","year":"1998","unstructured":"Schett, G., Redlich, K., Xu, Q., et al. (1998), Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest 102(2), 302\u2013311.","journal-title":"J Clin Invest"},{"issue":"2","key":"BF02686079_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.autrev.2005.08.006","volume":"5","author":"G. S. Panayi","year":"2006","unstructured":"Panayi, G. S. and Corrigall, V. M. (2006), BiP regulates autoimmune inflammation and tissue damage. Autoimmun Rev 5(2), 140\u2013142.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"BF02686079_CR54","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.humimm.2006.03.010","volume":"67","author":"W. van Eden","year":"2006","unstructured":"van Eden, W. (2006), Immunoregulation of autoimmune diseases. Human Immunol 67(6), 446\u2013453.","journal-title":"Human Immunol"},{"issue":"1","key":"BF02686079_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00281-003-0128-7","volume":"25","author":"B. J. Prakken","year":"2003","unstructured":"Prakken, B. J., Roord, S., Ronaghy, A., Wauben, M., Albani, S., and van Eden, W. (2003), Heat shock protein 60 and adjuvant arthritis: a model for T cell regulation in human arthritis. Springer Sem Immunopathol 25(1), 47\u201363.","journal-title":"Springer Sem Immunopathol"},{"issue":"1","key":"BF02686079_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00281-003-0131-5","volume":"25","author":"D. Kyburz","year":"2003","unstructured":"Kyburz, D., and Corr, M. (2003), The KRN mouse model of inflammatory arthritis. Springer Semin Immunopathol 25(1), 79\u201390.","journal-title":"Springer Semin Immunopathol"},{"issue":"2","key":"BF02686079_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/ar73","volume":"2","author":"C. Benoist","year":"2000","unstructured":"Benoist, C. and Mathis, D. (2000), A revival of the B cell paradigm for rheumatoid arthritis pathogenesis. Arthritis Res 2(2), 90\u201394.","journal-title":"Arthritis Res"},{"issue":"4","key":"BF02686079_CR58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/ni772","volume":"3","author":"I. Matsumoto","year":"2002","unstructured":"Matsumoto, I., Maccioni, M., Lee, D. M., et al. (2002), How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 3(4), 360\u2013365.","journal-title":"Nat Immunol"},{"issue":"1","key":"BF02686079_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/ar1476","volume":"7","author":"T. Kamradt","year":"2005","unstructured":"Kamradt, T. and Schubert, D. (2005), The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Res Ther 7(1), 20\u201328.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"BF02686079_CR60","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.4049\/jimmunol.172.7.4503","volume":"172","author":"D. Schubert","year":"2004","unstructured":"Schubert, D., Maier, B., Morawietz, L., Krenn, V. and Kamradt, T. (2004), Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol 172(7), 4503\u20134509.","journal-title":"J Immunol"},{"issue":"5","key":"BF02686079_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ni0502-411b","volume":"3","author":"D. Kassahn","year":"2002","unstructured":"Kassahn, D., Kolb, C., Solomon, S., Bochtler, P., and Illges, H. (2002), Few human autoimmune sera detect GPI. Nature Immunol 3(5), 411\u2013412.","journal-title":"Nature Immunol"},{"issue":"4","key":"BF02686079_CR62","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/art.10898","volume":"48","author":"I. Matsumoto","year":"2003","unstructured":"Matsumoto, I., Lee, D. M., Goldbach-Mansky, R., et al. (2003), Low prevalence of antibodies to glacose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum 48(4), 944\u2013954.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"BF02686079_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/art.20028","volume":"50","author":"F. A. van Gaalen","year":"2004","unstructured":"van Gaalen, F. A., Toes, R. E., Ditzel, H. J., et al. (2004b), Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. Arthritis Rheum 50(2), 395\u2013399.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"BF02686079_CR64","first-page":"17","volume":"31","author":"S. Iwaki-Egawa","year":"2004","unstructured":"Iwaki-Egawa, S., Matsuno, H., Yudoh, K., et al. (2004), High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen. J Rheumatol 31(1), 17\u201322.","journal-title":"J Rheumatol"},{"issue":"12","key":"BF02686079_CR65","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0167-5699(96)30064-9","volume":"17","author":"H. A. Menard","year":"1996","unstructured":"Menard, H. A. and el Amine, M. (1996), The calpain-calpastatin system in rheumatoid arthritis. Immunol Today 17(12), 545\u2013547.","journal-title":"Immunol Today"},{"issue":"1","key":"BF02686079_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/08916930400022582","volume":"38","author":"C. Vincent","year":"2005","unstructured":"Vincent, C., Nogueira, L., Clavel, C., Sebbag, M. and Serre, G. (2005), Autoantibodies to citrullinated proteins: ACPA. Autoimmunity 38(1), 17\u201324.","journal-title":"Autoimmunity"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02686079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02686079\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02686079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02686079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T20:27:40Z","timestamp":1684009660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02686079"}},"subtitle":["Pathogenetic players and diagnostic tools"],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":66,"aliases":["10.1007\/s12016-007-0017-8"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BF02686079"],"URL":"https:\/\/doi.org\/10.1007\/bf02686079","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]},"article-number":"23"}}